In Brief
Naturex acquires Decas to enter UTI ingredient market; TSI finalizes Yessamin deal; NattoPharma gains U.S. patent for vitamin K2; DSM appoints Goppelsroeder nutritionals head; more news in brief.
Naturex acquires Decas to enter UTI ingredient market; TSI finalizes Yessamin deal; NattoPharma gains U.S. patent for vitamin K2; DSM appoints Goppelsroeder nutritionals head; more news in brief.